InflammationIND-Stage
Lung Inflammation
Aviceda’s proprietary therapeutic ligands bind Siglecs with high affinity to profoundly down-regulate immune cell activation and the production of inflammatory mediators to attenuate cytokine storm and resolve lung inflammation.
